Abstract

Periodontal pain is a public health problem derived from different conditions, including periodontal diseases, prosthetic complications, and even extractions performed by dentist. There are various treatments to control acute dental pain, being the administration of analgesics, such as Lysine Clonixinate (LC), a common practice. Unfortunately, higher and repeated dosages are usually required. The purpose of this work was to develop a prolonged release pharmaceutical form as an alternative treatment for dental pain. Hence, we conceived a film based on guar gum and loaded different concentrations of LC. We evaluated the film's appearance, brittleness, strength, and flexibility, and then chose one formulation for adequate characteristics. Subsequently, we assessed the morphology, thermal behavior, and swelling properties of the films (LC-free and -loaded). Finally, we performed the release studies of LC from the films in vitro using a simulated saliva medium and employed several mathematical models to evaluate the release kinetics. Guar gum is a natural polymer obtained from the endosperm of Cyamopsis tetragonolobus that presents properties such as biosafety, biocompatibility, and biodegradability. Thus, it represents a potential excipient for use in pharmaceutical formulations. Moreover, our results revealed that the LC-loaded film presented a high adherence, suitable swelling behavior, high LC content, and a prolonged drug release. Therefore, the LC-loaded film may be considered a potential option to be applied as an alternative to treat dental pain.

Highlights

  • Periodontal pain is a condition generated by diseases such as periodontal disease, pericoronitis, and dental surgical procedures (1)

  • We developed an LCloaded polymeric film based on Guar gum (GG) and PVP to reduce the frequency of administration, intending to administer it on a single occasion

  • The correlation between the morphology of a drug delivery system and the drug release from the films is a critical aspect in evaluating new dosages forms

Read more

Summary

Introduction

Periodontal pain is a condition generated by diseases such as periodontal disease (gingivitis, periodontitis), pericoronitis, and dental surgical procedures (1). According to the FDI World Dental Federation, periodontal diseases affect 50% of the world population; it is a public health problem. This disease affects the gums, causing inflammation and damaging the bones and supporting tissue (2). An analgesic commonly used in periodontal disease is Lysine Clonixinate (LC) due to its high safety and efficacy. Its frequency of administration varies from [3,4] dosages a day with a dose of [125-250] mg (3). New dosage forms for its administration are needed

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call